A-33 | Impact of COVID-19 on Percutaneous Coronary Intervention Outcomes: Insight from National Inpatient Sample

The COVID-19 pandemic significantly impacted patients and healthcare systems worldwide, potentially impacting the outcomes of percutaneous coronary interventions (PCI). We investigated hospitalized for PCI during first year pandemic. identified all in 2020 using National Inpatient Sample (NIS), identifying those with or without concurrent COVID-19. Logistic linear regression was used analyses associations, adjustment potential confounders. defined significance as a 2-tailed p-value 0.05. There were 331,519 hospitalizations 2020, which 3,045 included infection. After adjusting age, race, sex, hospital bed size, location, teaching status, insurance income level, Elixhauser comorbidities; we found that undergoing infection had higher rate in-hospital mortality (aOR 8.28, 95% CI 6.51- 10.5), mechanical ventilation use 3.47, 2.78-4.34), vasopressor 2.56, 1.69 - 3.87), hemodialysis 1.62, 1.11- 2.36), length stay 3.70, 2.76- 4.64) total charges $52,938 (p<0.001) than Our study rates adverse This can be attributed longer symptoms-to-first medical contact time other system delays present